Longitude Capital
Zack Ely is a Senior Associate at Longitude Capital, having transitioned to this role in September 2022 after serving as a Longitude Research Fellow from 2021 to 2022. Prior to joining Longitude Capital, Zack worked as a Graduate Student Researcher at the MIT Koch Institute for Integrative Cancer Research and as a Research Affiliate at the Broad Institute of MIT and Harvard from 2019 to 2022. Zack's research experience began at Vanderbilt University, where an undergraduate researcher role was held from January 2016 to September 2018. Zack earned a PhD in Oncology and Cancer Biology from the Massachusetts Institute of Technology in October 2022 and holds a Bachelor's degree in Molecular Biology from Vanderbilt University.
This person is not in any teams
This person is not in any offices
Longitude Capital
Longitude Capital specializes in making venture growth investments in biotechnology, medical technology and health solutions companies that seek to improve clinical outcomes, enhance quality of life and/or reduce system costs. Longitude Capital invests in both privately held and publicly traded life science companies through a variety of investment approaches.